FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

AMIN JACK
2. Issuer Name and Ticker or Trading Symbol

AMEXDRUG CORP [ AXRX ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      __ X __ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Pres,CEO,CFO,Sec'y,Treasurer
(Last)          (First)          (Middle)

8909 WEST OLYMPIC BOULEVARD, SUITE 208
3. Date of Earliest Transaction (MM/DD/YYYY)

6/18/2009
(Street)

BEVERLY HILLS, CA 90211
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.001 par   6/18/2009     P    500   A $1.01   7755500   (1) D    
Common Stock, $0.001 par   6/19/2009     P    500   A $1.01   7756000   (1) D    
Common Stock, $0.001 par   6/23/2009     P    1500   A $1.1   7757500   (1) D    
Common Stock, $0.001 par   6/26/2009     P    500   A $1.4   7758000   (1) D    
Common Stock, $0.001 par   7/6/2009     P    100   A $2   7758100   (1) D    
Common Stock, $0.001 par   8/7/2009     P    1000   A $1.35   7759100   (1) D    
Common Stock, $0.001 par   9/8/2009     P    2   A $1.35   7759102   (1) D    
Common Stock, $0.001 par   9/16/2009     P    100   A $1.35   7759202   (1) D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:
( 1)  Jack Amin's wife, Nora Amin, also owns 421,083 shares of Amexdrug Corporation common stock which have not been included in the total amount of Amexdrug Corporation common stock beneficially owned by Jack Amin. Mr. Amin disclaims beneficial ownership of the 421,083 shares held by his wife.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
AMIN JACK
8909 WEST OLYMPIC BOULEVARD
SUITE 208
BEVERLY HILLS, CA 90211
X X Pres,CEO,CFO,Sec'y,Treasurer

Signatures
/s/ Jack Amin 11/13/2009
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
AmexDrug (CE) (USOTC:AXRX)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more AmexDrug (CE) Charts.
AmexDrug (CE) (USOTC:AXRX)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more AmexDrug (CE) Charts.